Higher frequency of regulatory T suppressive activity cells in the elderly and increased in neurodegeneration

被引：194
作者：
Rosenkranz, Daniela
Weyer, Sascha
Tolosa, Eva
Gaenslen, Alexandra
Berg, Daniela
Leyhe, Thomas
Gasser, Thomas
Stoltze, Lars
机构：
[1] Hertic Inst Clin Brain Res, Dept Gen Neurol, D-72076 Tubingen, Germany
[2] Univ Hosp, Dept Gen Psychiat & Psychotherapy, Tubingen, Germany
[3] Dept Neurodegenerat Disorders, Tubingen, Germany
[4] Dept Cellular Neurol, Tubingen, Germany
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2007年 / 188卷 / 1-2期
关键词：
immune regulation; Alzheimer's disease; Parkinson disease; ageing; inflammation;
D O I：
10.1016/j.jneuroim.2007.05.011
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The involvement of regulatory T cells (Treg) in autoinumme-disease development has been demonstrated. However, their alteration during ageing and age-related diseases has not been thoroughly investigated yet. Alzheimer (AD) and Parkinson disease (PD), are related to proteinmisfolding and are accompanied by neuroinflarnmation. Since, it has been hypothesized that the neuroinflainmation attempts to prevent disease development, we speculated that changes in Treg might affect any relevant irru-nune mechanism. The analysis of Treg from AD and PD patients as well as non-affected individuals, revealed that the frequency of Treg (CD4(+)Foxp3(+)) increases with age and is accompanied by intensified suppressive activity for Treg in patients. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码：117 / 127
页数：11
相关论文
共 54 条
[11]   Reduced levels of amyloid β-peptide antibody in Alzheimer disease [J].
Du, Y ;
Dodel, R ;
Hampel, H ;
Buerger, K ;
Lin, S ;
Eastwood, B ;
Bales, K ;
Gao, F ;
Moeller, HJ ;
Oertel, W ;
Farlow, M ;
Paul, S .
NEUROLOGY, 2001, 57 (05) :801-805
[12]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[13]   Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease [J].
Frenkel, D ;
Maron, R ;
Burt, DS ;
Weiner, HL .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (09) :2423-2433
[14]  
GERSHON RK, 1971, IMMUNOLOGY, V21, P903
[15]   The clinical features of thin basement membrane nephropathy [J].
Gregory, MC .
SEMINARS IN NEPHROLOGY, 2005, 25 (03) :140-145
[16]   PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].
HOEHN, MM ;
YAHR, MD .
NEUROLOGY, 1967, 17 (05) :427-&
[17]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[18]   WHAT FEATURES IMPROVE THE ACCURACY OF CLINICAL-DIAGNOSIS IN PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY [J].
HUGHES, AJ ;
BENSHLOMO, Y ;
DANIEL, SE ;
LEES, AJ .
NEUROLOGY, 1992, 42 (06) :1142-1146
[19]   ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES [J].
HUGHES, AJ ;
DANIEL, SE ;
KILFORD, L ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) :181-184
[20]   Neuroinflammatory processes in Parkinson's disease [J].
Hunot, S ;
Hirsch, EC .
ANNALS OF NEUROLOGY, 2003, 53 :S49-S58
123456